By Dr Pranab Gyawali, Consultant Gastroenterologist In my 25 years as a gastroenterologist treating patients with Crohns disease, ulcerative colitis (UC), and complex gut symptoms, it is only recently that I have seen such a massive surge of interest in BPC 157
For patients with recurrent vulvovaginal candidiasis (four or more episodes annually), management should include: Microscopy and culture to identify the Candida species An induction-maintenance regimen (e.g., fluconazole 150mg every 72 hours for three doses, followed by weekly maintenance for up to six months) Thorough review of predisposing factors Management strategies for patients on Ozempic should include: Optimising glycaemic control as the cornerstone of preventionreviewing HbA1c targets and adjusting diabetes medications as needed Completing the full course of antifungal treatment even if symptoms resolve early Treating sexual partners if they have symptoms (though routine partner treatment is not necessary for uncomplicated cases) Reviewing and addressing modifiable risk factors Considering prophylactic antifungal therapy for patients with frequent recurrences Patients should be reassured that yeast infections, whilst uncomfortable, are treatable and that continuing Ozempic is appropriate provided diabetes control is optimised
The authors propose that cysteamine/cystamine will soon be added to the mix of drugs that used to treat central nervous system diseases
WeightWatchers stock surged 25% following the news
these are topline results
IM protocols require 2225 gauge needles with 11.5 length to reach muscle tissue through the subcutaneous fat layer
